ISR Reports study finds SGS Life Sciences a stand-out Phase I service provider

Informing the drug development and commercialization industry Cary, N.C. – June 11, 2014 – Industry Standard Research (ISR) today announced the release of their “CRO Quality Benchmarking – Phase I Service Providers” report.  This research, based on in-depth surveys collected from 113 pharmaceutical Phase I decision-makers, indicates that SGS Life Sciences out-performs customers’ expectations across … Continued